AmacaThera is focused on developing a unique, injectable hydrogel platform technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.
AmacaThera’s proprietary hydrogels enable local, sustained release of small-molecule drugs, biotherapeutics and cells.
These scalable materials have broad utility in several models of disease by protecting encapsulated biomolecules from degradation and clearance via their unique inverse thermogelling properties.
website: https://www.amacathera.ca/